Abstract
Morvan’s syndrome is a rare disease characterized by peripheral nerve hyperexcitability, associated with CNS and autonomic systems involvement. High serum voltage-gated potassium channel (VGKC) antibody titers have been reported, and, till now, Morvan’s syndrome has been considered as a VGKC antibody associated disease. We describe a patient with Morvan’s syndrome associated with myasthenia gravis and a thymoma in his previous history, with surprisingly undetectable levels of VGKC antibodies. The clinical course is similar to those cases of Morvan’s syndrome with VGKC-Ab, except for the lack of response to plasma exchange, previously considered as the first choice treatment. Nevertheless, the good response to corticosteroids therapy and the association with myasthenia confirm an autoimmune origin of the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Maddison P (2006) Neuromyotonia. Clin Neurophysiol 117(10):2118–2127
Martinelli P, Patuelli A, Minardi C, Cau A, Riviera AM, Dal Pozzo F (1996) Neuromyotonia, peripheral neuropathy and myasthenia gravis. Muscle Nerve 19:505–510
Partanen VS, Soininen H, Saksa M, Riekkinen P (1980) Electromyographic and nerve conduction findings in a patient with neuromyotonia, normocalcemic tetany and small-cell lung cancer. Acta Neurol Scand 61:216–226
Zifko U, Drlicek M, Machacek E, Jellinger K, Grisold W (1994) Syndrome of continuous muscle fiber activity and plasmocytoma with IgM paraproteinemia. Neurology 44:560–561
Newsom-Davis, Mills KR (1993) Immunological associations of acquired neuromyotonia (Isaac’s syndrome). Report of five cases and literature review. Brain 116:453–469
Liguori R, Vincent A, Clover A et al (2001) Morvan’s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channel. Brain 124(12):2417–2426
Barber PA, Anderson NE, Vincent A (2000) Morvan’s syndrome associated with voltage gated K channel antibodies. Neurology 54(3):771–772
Madrid A, Gil-Peralta A, Gil-Neciga E, Gonzalez JR, Jarrin S (1996) Morvan’s fibrillary chorea: remission after plasmapheresis. J Neurol 243:350–353
Lee EK, Maselli RA, Ellis WG, Agius MA (1998) Morvan’s fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatr 65(6):857–862
Diaz-Manera J, Rojas-Garcia R, Gallardo E, Juarez C, Martinez-Domeno A et al (2007) Antibodies to AchR, MuSK, VGKC in a patient with myasthenia gravis, Morvan’s syndrome. Nat Clin Pract Neurol 3(7):405–410
Toosy AT, Burbridge SE, Pitkanen M, Loyal AS, Akanuma N et al (2008) Functional imaging correlates of fronto-temporal dysfunction in Morvan’s syndrome. J Neurol Neurosurg Psychiatry 79:734–735
Marino M, Muller-Hermelink HK (1985) Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 408(2–3):143–161
Tan KM, Lennon VA, Klein CJ et al (2008) Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 70(20):1883–1890
Kleopra KA, Elman LB, Lang B, Vincent A, Scherer SS (2006) Neuromyotonia and limbic encephalitis sera target mature shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain 129:570–584
Nagado T, Arimura K, Sonoda Y et al (1999) Potassium current suppression in patients with peripheral nerve hyperexcitability. Brain 122:2057–2066
Vincent A, Buckley C, Schott JM, Baker I, Dewar BK et al (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701–712
Samarasekera SR, Vincent A, Welch JL et al (2007) Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry 78(4):391–394
Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140
Acknowledgments
The authors are grateful to Dr. Francesca Andreetta, Besta Neurological Institute Milan, for the determination of the anti-VGKC antibody in serum.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rinaldi, C., Russo, C.V., Filla, A. et al. Course and outcome of a voltage-gated potassium channel antibody negative Morvan’s syndrome. Neurol Sci 30, 237–239 (2009). https://doi.org/10.1007/s10072-009-0041-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-009-0041-y